Eli Lilly Can't Slip Teva's Migraine Drug Patent Suit
By Carolyn Muyskens · October 4, 2022, 5:23 PM EDT
Drugmakers Eli Lilly and Co. and Teva Pharmaceuticals must take their patent dispute over rival migraine medications to a jury, a Massachusetts federal judge said Monday, denying the bulk of the...
To view the full article, register now.